Beierlein, M., Häberle, L., Nabieva, N., Maass, N., Aktas, B., Kümmel, S., . . . Fasching, P. A. (2025). Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial. International journal of cancer, 157(11), . https://doi.org/10.1002/ijc.70037
Chicago-Zitierstil (17. Ausg.)Beierlein, Milena, et al. "Invasive Disease-free and Overall Survival After (neo)adjuvant Chemotherapy in Postmenopausal Patients with Hormone Receptor-positive, HER2-negative Early Breast Cancer Treated with Upfront Letrozole: Experiences from the Phase IV PreFace Trial." International Journal of Cancer 157, no. 11 (2025). https://doi.org/10.1002/ijc.70037.
MLA-Zitierstil (9. Ausg.)Beierlein, Milena, et al. "Invasive Disease-free and Overall Survival After (neo)adjuvant Chemotherapy in Postmenopausal Patients with Hormone Receptor-positive, HER2-negative Early Breast Cancer Treated with Upfront Letrozole: Experiences from the Phase IV PreFace Trial." International Journal of Cancer, vol. 157, no. 11, 2025, https://doi.org/10.1002/ijc.70037.